MOH — authorised 27 January 2023
- Marketing authorisation holder: STEMLINE THERAPEUTICS INC
- Status: likely_approved
🇮🇱 Orserdu in Israel
MOH authorised Orserdu on 27 January 2023
Marketing authorisation
Orserdu in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Orserdu approved in Israel?
Yes. MOH authorised it on 27 January 2023.
Who is the marketing authorisation holder for Orserdu in Israel?
STEMLINE THERAPEUTICS INC holds the Israeli marketing authorisation.